Dementia and Geriatric Cognitive Disorders · 2011 · 24 citations · 22 references
Life SciencesNeurologyNeuroscienceAgingNeurobiology Of DiseaseNeurodegenerationAge-related Physiologic ChangesCerebrovascular DiseaseFolate DeficiencyStrokeBrain Atrophy In AgingHomocysteine ElevationHypertension In Older AdultsPlasma Folate BiomarkersSerum Folate StatusWhite Matter InvolvementWhite Matter LesionsWhite Matter Microstructure
We determined using serial MR imaging whether raised plasma homocysteine levels are associated with increased brain atrophy, white matter lesion (WML) progression or incidence of silent brain infarcts (SBIs) in older hypertensive subjects. Brain atrophy rates (0.58 ± 0.48% per year, mean ± SD) were significantly correlated with homocysteine (β = 0.46, p = 0.001 homocysteine; β = 0.44, p = 0.007 homocysteine/folate/B12 models) but not with folate or B12 levels. Progression of WML (0.08 ± 0.16%) was not associated with homocysteine level (B = 0.01, p = 0.29). New SBIs were uncommon. In older hypertensive individuals, plasma homocysteine levels are associated with increased rates of whole-brain atrophy but not WML progression.
22
Folate, Vitamin B12, and Serum Total Homocysteine Levels in Confirmed Alzheimer Disease
Robert Clarke, A. David Smith, Kim A. Jobst et al. · Archives of Neurology · 1998 · 1.4K citations
Medicine, Geriatric Medicine, Aging +16
The Study on Cognition and Prognosis in the Elderly (SCOPE)
Hans Lithell, Lennart Hansson, Ingmar Skoog et al. · Journal of Hypertension · 2003 · 1.4K citations · Full text